Claim/exemption information - Registry number 3504910
List of suggested corrective measures
Disclose a statement to the effect that the actual concentrations are withheld as a trade secret.
Disclose all headings as set out in column 1 of Schedule 1, specifically in section 1 “Identification” and section 16 “Other information.”
Disclose an adequate product odour.
Disclose either the name of the symbol or the symbol itself for each of the applicable product hazard classifications (see appendix 2).
Disclose the HMIRA registry number and date of decision granting the exemption, and clearly link which ingredients and concentrations are part of the subject of the claim for exemption under the HMIRA.
Disclose the additional hazard classifications for the product (see appendix 1).
Disclose the common name and synonyms for the ingredients listed in section 3 of the SDS.
Disclose the correct and complete LD50 and LC50 values (see appendix 6).
Disclose the hazard statements for each of the product hazard classification categories or subcategories (see appendix 3).
Disclose the information on personal protective equipment in section 6 of the SDS.
Disclose the precautionary statements for each of the product hazard classification categories or subcategories (see appendix 3).
Disclose the product oral and inhalation acute toxicity estimates (ATEs) of 5100 mg/kg (21% unknown) and 0.47 mg/L (78.25 % unknown), respectively (see appendix 6).
Disclose the relevant conditions for safe storage (see appendix 5).
Disclose the relevant first-aid measures for inhalation and skin contact (see appendix 4).
Disclose the relevant precautions for safe handling (see appendix 5).
Remove all forward slashes or diagonal marks in precautionary statements for which a choice is to be made.
Remove all forward slashes or diagonal marks in the hazard classifications for which a choice is to be made.